Periodontitis (PD) is an inflammation of the periodontium (tissues that surround and support the teeth) caused by an aggressive immune response to an increased number of pathogenic microorganisms in the oral cavity. This disease affects around 40% of human population and can lead to tooth loss. A few risk factors are associated with PD, including smoking, systemic diseases (rheumatoid arthritis, diabetes, cardiovascular diseases), poor dental hygiene, etc. The early stages of periodontitis are usually asymptomatic, resulting in delayed diagnosis of PD [1, 2]. In addition, PD complicates the endurance of dental implants. Overall, it is crucial to detect periodontitis before its progression and invent a highly specific method of treatment. Cells, involved in the immune response to an inflammatory disease, such as PD, can be regulated by miRNAs –short non-coding RNAs that can control expression of genes. The goal of the present study is to assess the potential of miRNA blocking as a therapy method for PD.
Healthy (PD–) and affected (PD+) gingival crevicular fluid (GCF, N=40) specimens were tested in order to determine the expression changes four miRNA (miR-140-3p, miR-145-5p, miR-146a-5p, miR-190-5p). In vitro experiments were also carried out for selected miRNAs expression evaluation. Untreated control (CT) cells were compared with three types of cell treatment: with inflammatory mediator IL-1β (IL-1β), miRNA inhibitors (INH), and both (IL+INH). Variation of miRNA expression was assessed by quantitative reverse transcription PCR (RT-qPCR).
Significant differences in miRNA levels between PD– and PD+ groups were not detected (P>0.05), while the amount of miR-146a-5p was significantly higher in the control/mild group than in moderate/severe PD group (P=0.0277). MiRNA changes were also associated with clinical-pathological parameter – bone loss (BL), as GCF samples from BL ≥ 20% cases compared to BL < 20% had a higher amount of miRNA-145-5p and lower amount of miRNA-146a-5p (P=0.0398 and P=0.0150, respectively). Statistically significant increase in miRNA-146a-5p expression after cells were treated with IL-1β (P<0.0001) and a decrease in miRNA-145-5p expression after exposure to miRNA inhibitors (P=0.0010) was disclosed by in vitro experiments.
The current study showed that there is a link between miR-146a-5p amount changes in GCF and PD severity. In vitro results suggest that after more experiments directed to miRNA blocking, it could be a future treatment option for periodontitis treatment.